急性特发性黄斑病变研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(No.82101147)


Research progress of acute idiopathic maculopathy
Author:
Affiliation:

Fund Project:

National Natural Science Foundation of China(No.82101147)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    急性特发性黄斑病变(AIM)是一种原因不明的,多累及黄斑区的炎症性病变,该疾病具有不同于其他黄斑病变的自然病程,常表现为流感样症状后突发视力下降,并随着疾病的消退逐渐恢复。独特的病史、多模态影像表现、以及完整的系统检查是确立AIM最终诊断的关键。由于其治疗与预后仍存在争议,且与多种视网膜脉络膜病变具有相似的临床表现和病理改变,临床上不易鉴别,因此文章就其发病机制、临床症状及多模式影像特点、诊断及鉴别诊断、治疗及预后进行综述,以期更全面地认识AIM,减少误诊误治。

    Abstract:

    Acute idiopathic maculopathy(AIM)is an inflammatory lesion of unknown cause that primarily affects the macula. It follows a unique natural course, distinct from other maculopathy, often manifesting as a sudden loss of visual acuity followed by flu-like symptoms that gradually resolve as the disease subsides. A comprehensive understanding of the unique history, multimodal imaging, and a thorough systematic examination are crucial in determining the final diagnosis of AIM. The treatment and prognosis of AIM remain controversial. Meanwhile, it presents similar clinical manifestations and pathological changes to various chorioretinopathy, posing challenges for clinical differentiation. This article provides a review of its pathogenesis, clinical symptoms, multimodal imaging features, diagnosis and differential diagnosis, treatment and prognosis, in order to reduce misdiagnosis and mistreatment while enhancing comprehension of AIM.

    参考文献
    相似文献
    引证文献
引用本文

贾一然,姜利斌,汪朝阳,等.急性特发性黄斑病变研究进展.国际眼科杂志, 2024,24(11):1738-1742.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-05-26
  • 最后修改日期:2024-09-13
  • 录用日期:
  • 在线发布日期: 2024-10-18
  • 出版日期:
文章二维码